Status:
RECRUITING
Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
Lead Sponsor:
Region Stockholm
Collaborating Sponsors:
Karolinska Institutet
Södersjukhuset (Stockholm South General Hospital)
Conditions:
Endometriosis
Eligibility:
FEMALE
18-45 years
Brief Summary
Endometriosis is a chronic, benign, estrogen-dependent disease characterized by endometrial tissue that is implanted outside the uterus into the ovaries, intestines, or peritoneum but also outside the...
Eligibility Criteria
Inclusion
- I
- women of reproductive age (18-45) who are operated because of suspected endometriosis (dysmenorrhea, dyspareunia, infertility, etc.) (patient group)
- women of reproductive age (18-45) who are operated for other benign gynecological causes with laparoscopy (ovarian cysts, sterilization, fibroids, etc.) and are found without macroscopic endometriosis perioperatively and confirmed with blind biopsies (control group
- talk swedish or english in order to complete questionnaires and give informed consent for their participation in the study.
Exclusion
- BMI\> 40
- postmenopausal women
- premature ovarian failure
- pelvic inflammatory disease (PID)
- current or previous malignancy
- pregnancy and 6 months postpartum
- corticosteroids in the last 3 months
- pituitary, kidney, liver, adrenal disease
- endometrial hyperplasia or endometrial polyp
- cardiovascular or systemic inflammatory diseases.
Key Trial Info
Start Date :
May 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT05339451
Start Date
May 4 2023
End Date
December 31 2026
Last Update
February 24 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Universitetssjukhus Huddinge
Stockholm, Huddinge, Sweden
2
Södersjukhuset Kvinnokliniken
Stockholm, Stockholm County, Sweden
3
Akademiska Uppsala
Uppsala, Sweden